G. Portier
Papers
1
Total Citations
14
H-Index
1
About
G. Portier is a leading French colorectal surgeon whose research has fundamentally shaped the management of low rectal cancer, particularly through organ-preserving strategies. His major contribution lies in pioneering the GRECCAR 2 randomized phase 3 trial, which compared local excision versus total mesorectal excision in patients with a good response after neoadjuvant radiochemotherapy for T2-T3 low rectal cancer. This landmark study, published in 2014 and cited over 140 times, provided critical preliminary evidence that selected patients could avoid radical surgery without compromising oncological outcomes, thereby reducing permanent stoma rates and preserving quality of life. Portier’s work has been instrumental in advancing the paradigm of watch-and-wait and local excision approaches, influencing international guidelines. His research continues to drive the field toward more personalized, less invasive treatments for rectal cancer, making him a key figure in surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1